CYT-100

N/A

Report date: 2023/02/18 19:35:00

Base Information

Drug NameCYT-100

Drug Alias NameCYT-100

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy

Mechanisms of ActionNatural killer cell replacementsImmunologic cytotoxicity

TargetsNot applicable

Therapy Area/IndicationsLiver NeoplasmsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCytovia Inc

China Registration ClassN/A

Develop Information

Active CompaniesCytovia Inc

Inactive CompaniesN/A

Active IndicationsLiver NeoplasmsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A